ResearcherUniversitair Ziekenhuis BrusselNo recent work listed
Jean-Luc Van Laethem
Known by name at one institution; no external author ID yet. Name as it appears in ClinicalTrials.gov.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 0
- Pancreatic cancer trials
- 3 (principal investigator on 2)
- Pancreatic cancer grants
- 0
- Collaborators
- 2
2003: 1 trial · 2004: none · 2005: none · 2006: none · 2007: none · 2008: none · 2009: none · 2010: none · 2011: none · 2012: 1 trial · 2013: 1 trial
Trials 3
- Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Pancreatic Cancer Principal investigator NCT01715142↗
- Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Vismodegib Before Surgery in Pancreatic Cancer Principal investigator NCT01713218↗
- Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer Study chair NCT00064207↗
Closest collaborators
The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Volker G. Budach · 1 shared trial, 2003
- Pascal R. Hammel · 1 shared trial, 2003
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.